ArticleBMC veterinary research2025
Usefulness of neurological assessment scales in prognosis of meningoencephalitis of unknown origin in Yorkshire Terriers.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical presentation, prognostic factors, and outcomes of meningoencephalitis of unknown origin in older dogs.Journal of veterinary internal medicine · 2026Article
- Correction: Usefulness of neurological assessment scales in prognosis of meningoencephalitis of unknown origin in Yorkshire Terriers.BMC veterinary research · 2025Article
- Of potential new treatment targets and polythetic approach in meningoencephalitis of unknown origin: a review.Frontiers in veterinary science · 2024Review
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAttempts to determine the prognostic factors that affect the survival time of canine patients with meningoencephalitis of unknown origin (MUO) have produced highly variable results. Scaled complex ratings to predict general outcomes are required. Scaled rating was recently proven to help predicting prognosis in general MUO population of dogs. However, Yorkshire Terriers (YST) are predisposed to necrotizing meningoencephalitis, especially necrotizing leukoencephalitis, which more frequently manifests itself with forebrain lesions and may exhibit a distinct disease course compared to granulomatous meningoencephalitis. This study aimed to determine the usefulness of neurological assessment scales in the prognosis of YST with MUO. The study population comprised 127 YST which met inclusion criteria for a highly probable diagnosis of MUO. This multicentre, cohort study was designed as a retrospective review of medical records. Based on documented neurological examinations, animals were scored on three scales: the Modified Glasgow Coma Scale, Neuro Disability Scale 1 (Smith et al.), and Neuro Disability Scale 2 (Gonçalves et al.). The association between the scores and survival time was investigated over three periods of time - 7 days, 100, and 365 days (1 year) after onset of clinical signs.
resultsAll scales were significantly associated (p < 0.001) with MUO-specific survival and death of MUO within the first 7 days and had high prognostic accuracy in terms of short-term prognosis. None of the scales was significantly associated with the probability of survival after 100 or 365 days. Dogs with unilateral lesions on magnetic resonance images (MRI) had approximately 12- and threefold higher odds of surviving up to 100 and 365 days, respectively, than dogs with bilateral lesions on MRI. Dogs heavier than 3.2 kg at presentation had approximately sixfold higher odds of survival up to day 365.
conclusionsThe study provides strong evidence for a high short-term prognostic accuracy of the three neurological assessment scales in YST with MUO - the scales seem to be very useful in predicting death within the first week of the onset of MUO. However, the scales do not appear to have prognostic value in the longer time frame. However, the presence of unilateral MRI changes and dog's body weight may assist with medium- and long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.